ArticleAnnals of medicine2025

Genetic variations in CYP2A6 predict efficacy of neoadjuvant letrozole concurrent with chemotherapy in locally advanced hormone receptor-positive breast cancer.

Yifan Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.